Adults with hidradenitis suppurativa were at a greater risk for noninfectious uveitis than control individuals, which ...

The following is a summary of “Exploring itch in hidradenitis suppurativa with lessons from atopic dermatitis and psoriasis,” ...

Patients with Hidradenitis Suppurativa (HS) are at a significantly higher risk of obstructive sleep apnea (OSA) compared to ...

Goldman Sachs analyst Richard Law upgraded MoonLake Immunotherapeutics (MLTX) to Buy from Neutral with a price target of $82, up from $62. The ...

Panelist discusses how delayed medical diagnosis causes significant economic burden through increased treatment costs, prolonged health care interventions, reduced patient productivity, and higher ...

MoonLake Immunotherapeutics is set to release results from both the phase 3 VELA-1 and VELA-2 studies in mid-2025. Click here ...

UCB, a global biopharmaceutical company, announced today that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX® (bimekizumab-bkzx) is now available. These ...

HC Wainwright restated their buy rating on shares of InflaRx (NASDAQ:IFRX – Free Report) in a research report released on Thursday morning,Benzinga reports. The brokerage currently has a $8.00 price ...

UCB announced that a single-injection 2 mL prefilled syringe and autoinjector, each containing 320 mg of BIMZELX is now available.

MoonLake Immunotherapeutics, a clinical-stage biotech firm valued at $2.6 billion, is generating excitement with its ...